Abstract
The presence of pericardial effusion in neonates usually indicates a poor prognosis. Here, we report a case of isolation of cardiac tamponade in a newly born. This may be related to vertical human parvovirus B19, an infection with atypical clinical manifestation. Any neonate with unexplained fetal pericardial effusion should always be tested for parvovirus B19 infection, even in the absence of known and proved fetal exposure. Despite the etiology of a tamponade the only reasonable procedure is a surgical evacuation during diagnosis.
Similar content being viewed by others
References
Sekar P, Hornberger LK, Smallhorn JS. A case of restrictive cardiomyopathy presenting in fetal life with an isolated pericardial effusion. Ultrasound Obstet Gynecol. 2010; 35:369–372
Yezewski KA, Ferroni KM. Very large isolated fetal pericardial effusion with spontaneous resolution. Journal of Diagnostic Medical Sonography. 2004; 20:194–197
Yaegashi N, Niinuma T, Chisaka H, Watanabe T, Uehara S, Okamura K, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect. 1998; 37:28–35
Sarafidis K, Drossou-Agakidou V, Evdoridou I, Petridou S, Hatzisevastou-Loukidou H, Dadamojas C, et al. Hydrothorax as a sole manifestation of congenital parvovirus B19 infection. Am J Perinatol. 2008; 25:551–554
Savarese I, De Carolis MP, Costa S, De Rosa G, De Carolis S, Lacerenza S, et al. Atypical manifestations of congenital parvovirus B19 infection. Eur J Pediatr. 2008; 167:1463–1466
Keeler ML. Human parvovirus B-19: not just a pediatric problem. J Emerg Med. 1992; 10:39–44
Parilla BV, Tamura RK, Ginsberg NA. Association of parvovirus infection with isolated fetal effusions. Am J Perinatol. 1997; 14:357–358
Dijkmans AC, de Jong EP, Dijkmans BA, Lopriore E, Vossen A, Walther FJ, et al. Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol. 2012; 24:95–101
Beigi RH, Wiesenfeld HC, Landers DV, Simhan HN. High rate of severe fetal outcomes associated with maternal parvovirus B19 infection in pregnancy. Infect Dis Obstet Gynecol. 2008; 2008:524601
Weiffenbach J, Bald R, Gloning KP, Minderer S, Gärtner BC, Weidner A, et al. Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus B19 infection. J Infect Dis. 2012; 205:782–788
Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152:257–265
Donders GG, Van Lierde S, Van Elsacker-Niele AM, Moerman P, Goubau P, Vandenberghe K. Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis J. 1994; 13:234–236
Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol. 1990; 75:501–504
Dieck D, Schild RL, Hansmann M, Eis-Hübinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn. 1999; 19:1119–1123
Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J. 2002; 21:1133–1136
Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S, et al. Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol. 1991; 35:110–115
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Jaworski, R., Haponiuk, I., Irga-Jaworska, N. et al. Critical cardiac tamponade in newborn, life-saving emergency interventions and possibility of parvovirus B19 congenital infection. cent.eur.j.med 8, 420–423 (2013). https://doi.org/10.2478/s11536-013-0189-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11536-013-0189-y